ALK and non-small cell lung carcinoma: Intrestingly in a recently published analysis in patients with ALK and EGFR positive NSCLC with brain metastases and treatment with newer generation TKIs, upfront SRS to brain metastases was associated with imptroved time-to-CNS progression and local CNS control, however no benefit with regards to OS was observed.